|
Variables | N | Case/Control | M-allele vs. W-allele | MW vs. WW | MM + MW vs. WW | MM vs. WW | MM vs. MW + WW |
ZFHX3 rs2106261 | OR(95%CI) PhP I2 | OR(95%CI) PhP I2 | OR(95%CI) PhP I2 | OR(95%CI) PhP I2 | OR(95%CI) PhP I2 |
|
Total | 7 | 3674/8990 | 1.39(1.31–1.47)0.117 0.000 41.1% | 1.37(1.18–1.59)0.007 0.000 66.5% | 1.49(1.30–1.70)0.011 0.000 63.6% | 1.96(1.73–2.21)0.317 0.000 14.8% | 1.70(1.52–1.90)0.643 0.000 0.0% |
|
SOC |
HB | 4 | 1654/3675 | 1.51(1.38–1.64)0.302 0.000 17.7% | 1.57(1.38–1.79)0.156 0.000 42.5% | 1.68(1.49–1.90)0.151 0.000 43.4% | 2.20(1.82–2.66)0.388 0.000 0.7% | 1.73(1.45–2.07)0.520 0.000 0.0% |
PB | 3 | 2020/5315 | 1.31(1.21–1.41)0.321 0.000 0.0% | 1.17(1.04–1.30)0.584 0.007 0.0% | 1.29(1.16–1.43)0.655 0.000 0.0% | 1.81(1.54–2.12)0.417 0.000 0.0% | 1.68(1.45–1.94)0.384 0.000 0.0% |
|
Genotype |
TaqMan | 2 | 650/914 | 1.55(1.33–1.80) 0.740 0.000 0.0% | 1.82(1.46–2.27) 0.668 0.000 0.0% | 1.87(1.52–2.30) 0.674 0.000 0.0% | 2.06(1.48–2.86) 0.884 0.000 0.0% | 1.51(1.11–2.06) 1.000 0.000 0.0% |
Other | 2 | 1004/2761 | 1.47(1.21–1.80)0.068 0.000 70.1% | 1.45(1.24–1.70)0.123 0.000 58.1% | 1.59(1.19–2.12)0.057 0.002 72.4% | 1.47(1.21–1.80)0.095 0.000 64.1% | 1.86(1.50–2.32)0.279 0.000 14.5% |
HRM | 3 | 2020/5315 | 1.31(1.21–1.41)0.647 0.000 0.0% | 1.17(1.04–1.30)0.584 0.007 0.0% | 1.29(1.16–1.43)0.655 0.000 0.0% | 1.81(1.54–2.12)0.417 0.000 0.0% | 1.68(1.45–1.94)0.384 0.000 0.4% |
|
PRRX1 rs3903239 |
Total | 3 | 1045/1407 | 0.82(0.63–1.07)0.023 0.147 73.5% | 0.83(0.77–0.99)0.522 0.036 0.0% | 0.79(0.67–0.94)0.137 0.006 49.7% | 0.68(0.35–1.32)0.011 0.253 78.0% | 0.75(0.42–1.31)0.023 0.310 73.5% |
|